Givaudan Singapore PTE Ltd
⚠️ Moderate Risk
FEI: 3003215480 • Singapore • SINGAPORE
FEI Number
3003215480
Location
Singapore
Country
SINGAPOREAddress
1 Woodlands Avenue 8, , Singapore, , Singapore
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
FILTHY
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the article appears to consist in whole or in part of a filthy, putrid, or decomposed substance or be otherwise unfit for food.
Refusal History
Frequently Asked Questions
What is Givaudan Singapore PTE Ltd's FDA import refusal history?
Givaudan Singapore PTE Ltd (FEI: 3003215480) has 2 FDA import refusal record(s) in our database, spanning from 6/24/2004 to 6/24/2004.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Givaudan Singapore PTE Ltd's FEI number is 3003215480.
What types of violations has Givaudan Singapore PTE Ltd received?
Givaudan Singapore PTE Ltd has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Givaudan Singapore PTE Ltd come from?
All FDA import refusal data for Givaudan Singapore PTE Ltd is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.